CHANCES
Institut Paoli-Calmettes
Institut Paoli-Calmettes
Centre Hospitalier Universitaire Vaudois
Universitair Ziekenhuis Brussel
Kaiser Permanente
University Medical Center Groningen
Massachusetts General Hospital
Immix Biopharma, Inc.
Kineta Inc.
Namida Lab
Shanghai Yunying Medical Technology
Ankara Yildirim Beyazıt University
Assistance Publique - Hôpitaux de Paris
MiRXES Pte Ltd
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Impact Therapeutics, Inc.
Charite University, Berlin, Germany
Blue Note Therapeutics
Main Line Health
Imperial College London
Assistance Publique - Hôpitaux de Paris
Istanbul Saglik Bilimleri University
Weprom
Shenzhen Kangzhe Pharmaceutical Co., Ltd.
Shanghai Fengxian District Central Hospital
University Hospital Southampton NHS Foundation Trust
SpeciCare
Medical University Innsbruck
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Aalborg University
Petra Pharma
Samyang Biopharmaceuticals Corporation
Instituto do Cancer do Estado de São Paulo
The University of The West Indies
Placon Therapeutics
Xuanwu Hospital, Beijing
Quantgene Inc.
University Hospital, Strasbourg, France
Institut National de la Santé Et de la Recherche Médicale, France
Poveda, Andrés, M.D.
Heidelberg University
SPGO Research Mannheim GmbH
Shenzhen Second People's Hospital
Women's College Hospital
Arno Therapeutics
The National Institute of Lymphology
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Aarhus
National Cancer Institute (NCI)